Trial intelligence / Profile preview

PEP005 Gel in Photo-damaged Skin

NCT01214577Phase 2Completed

Sponsor
Peplin
Start
Oct 2010
Primary completion
Jan 2011
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ingenol mebutate in photoaging, sponsored by Peplin. Started Oct 2010; status: completed.

02

Drugs

ingenol mebutate
03

Conditions

photoaging

Beyond the preview

Go deeper on NCT01214577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01214577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call